SMS Lifesciences India has informed that the Board of Directors of the Company at its Meeting held today, November 10, 2025, have considered and approved the unaudited [Standalone & Consolidated] financial results for the quarter and half year ended September 30, 2025, as recommended by the Audit Committee. In this regard, the company has enclosed a copy of the following: 1) Unaudited financial results (Standalone & Consolidated) for the quarter and half year ended September 30,2025, along with limited review report. 2) Statement of Assets & Liabilities and Cash-flow statement. 3) Related Party Transactions for the half year ended September 30, 2025. The meeting of the Board commenced at 02.45 pm and concluded at 4.15 pm.
The above information is a part of company’s filings submitted to BSE.
